Title: A Walk in the PARP: Remodeling the Landscape of Newly Diagnosed Advanced Ovarian Cancer
December 15, 2020 at 1:45 PM
Speakers:
- Jonathan Ledermann, MD, FRCP, UCL Cancer Institute, U.K.
- Alexandra Leary, MD, PhD, Gustave Roussy Institute of Oncology, France
- Frederik Marmé, MD PhD, University of Heidelberg, Germany
Program:
- Genetic drivers of ovarian cancer development – Dr. Leary
- Comparison of pharmacologic properties of approved and investigational PARP inhibitors - Dr. Marmé
- PARP inhibitors in recurrent ovarian cancer – Dr. Ledermann
- Ongoing research with PARP inhibitors – panel discussion
